Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.

Archives of virology - 1 Apr 2018

Boglione Lucio, Cusato Jessica, Pinna Simone Mornese, De Nicolò Amedeo, Cariti Giuseppe, Di Perri Giovanni, D'Avolio Antonio

Abstract excerpt

Mixed cryoglobulinemia (MC) is the most common extrahepatic manifestation of chronic hepatitis C (CHC), with the presence of symptoms in 10-15% of cases. There have been encouraging data regarding immunological and clinical responses in patients treated with the novel combinations of direct-acting antivirals (DAAs), but the role of ribavirin (RBV) in the treatment of MC has not yet been demonstrated. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Naphthylamine
Share to Anilides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryoglobulinemia

Share to Lactams, Macrocyclic

Share to Macrocyclic Compounds

Share to Pyrrolidines

Share to Ritonavir

Share to Uracil

Source

Identifiers

PMID: 29318374
DOI: 10.1007/s00705-017-3684-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.PMID 29318374Read ↗

Interferon-free regimens for hepatitis C: combine and conquer.Semantic proximity Read ↗

Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment.Semantic proximity Read ↗

Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.Semantic proximity Read ↗

Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.Semantic proximity Read ↗

Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia.Semantic proximity Read ↗

Role of ribavirin in interferon-free therapy for the treatment of hepatitisC virus.Semantic proximity Read ↗

Clinical and virological findings in mixed cryoglobulinaemia.Semantic proximity Read ↗

Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes.Semantic proximity Read ↗

Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?Semantic proximity Read ↗

Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.Semantic proximity Read ↗

Hepatitis C virus-mixed cryoglobulinemia-lymphoma relationship.Semantic proximity Read ↗

Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.